1st Global Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$2.61M Sell
31,705
-512
-2% -$41.8K 0.3% 41
2017
Q1
$2.71M Buy
32,217
+3,311
+11% +$265K 0.32% 41
2016
Q4
$2.13M Buy
28,906
+852
+3% +$63.5K 0.27% 48
2016
Q3
$2.25M Sell
28,054
-489
-2% -$39.1K 0.3% 42
2016
Q2
$2.25M Buy
28,543
+11,751
+70% +$885K 0.31% 38
2016
Q1
$1.21M Buy
16,792
+140
+0.8% +$10.6K 0.17% 88
2015
Q4
$1.4M Buy
+16,652
New +$1.38M 0.21% 61

Other funds holding LLY

1st Global Advisors's LLY Position: Q2 2017 in Review

1st Global Advisors reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2017, selling an estimated $41.8K and leaving 31,705 shares worth $2.61M. The position accounts for 0.3% of the portfolio, ranked #41.

1st Global Advisors first reported a position in LLY in Q4 2015 and has held it in 7 quarters since. The position peaked at $2.71M in Q1 2017. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • 1st Global Advisors held 31,705 shares of Eli Lilly worth $2.61M as of Q2 2017.
  • 1st Global Advisors sold 512 Eli Lilly shares in Q2 2017, an estimated $41.8K.
  • Eli Lilly made up 0.3% of 1st Global Advisors's portfolio in Q2 2017, its #41 holding.
  • 1st Global Advisors first reported a position in Eli Lilly in Q4 2015 and has held it in 7 quarters since.
  • 1st Global Advisors's Eli Lilly position peaked at $2.71M in Q1 2017.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.